SRNE
Commonwealth Equity Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-134,037
| Closed | -$118K | – | 3907 |
|
|
2022
Q4 | $118K | Sell |
134,037
-11,192
| -8% | -$9.85K | ﹤0.01% | 3382 |
|
|
2022
Q3 | $228K | Sell |
145,229
-20,488
| -12% | -$32.2K | ﹤0.01% | 3062 |
|
|
2022
Q2 | $333K | Buy |
165,717
+9,415
| +6% | +$18.9K | ﹤0.01% | 2744 |
|
|
2022
Q1 | $364K | Buy |
156,302
+72,340
| +86% | +$168K | ﹤0.01% | 2797 |
|
|
2021
Q4 | $390K | Sell |
83,962
-5,300
| -6% | -$24.6K | ﹤0.01% | 2739 |
|
|
2021
Q3 | $681K | Buy |
89,262
+3,380
| +4% | +$25.8K | ﹤0.01% | 2237 |
|
|
2021
Q2 | $832K | Buy |
85,882
+11,445
| +15% | +$111K | ﹤0.01% | 2057 |
|
|
2021
Q1 | $615K | Sell |
74,437
-11,394
| -13% | -$94.1K | ﹤0.01% | 2156 |
|
|
2020
Q4 | $585K | Buy |
85,831
+20,478
| +31% | +$140K | ﹤0.01% | 2038 |
|
|
2020
Q3 | $728K | Sell |
65,353
-34,413
| -34% | -$383K | ﹤0.01% | 1694 |
|
|
2020
Q2 | $626K | Buy |
99,766
+76,246
| +324% | +$478K | ﹤0.01% | 1728 |
|
|
2020
Q1 | $43K | Buy |
23,520
+13,100
| +126% | +$24K | ﹤0.01% | 2698 |
|
|
2019
Q4 | $35K | Sell |
10,420
-6,526
| -39% | -$21.9K | ﹤0.01% | 2830 |
|
|
2019
Q3 | $36K | Buy |
16,946
+6,763
| +66% | +$14.4K | ﹤0.01% | 2764 |
|
|
2019
Q2 | $27K | Hold |
10,183
| – | – | ﹤0.01% | 2728 |
|
|
2019
Q1 | $48K | Sell |
10,183
-29,414
| -74% | -$139K | ﹤0.01% | 2665 |
|
|
2018
Q4 | $95K | Buy |
39,597
+14,916
| +60% | +$35.8K | ﹤0.01% | 2499 |
|
|
2018
Q3 | $108K | Sell |
24,681
-112,556
| -82% | -$493K | ﹤0.01% | 2630 |
|
|
2018
Q2 | $988K | Buy |
137,237
+9,146
| +7% | +$65.8K | 0.01% | 1289 |
|
|
2018
Q1 | $659K | Buy |
+128,091
| New | +$659K | ﹤0.01% | 1511 |
|